Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
169 hedge funds and large institutions have $2.08B invested in Amedisys in 2017 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 71 increasing their positions, 47 reducing their positions, and 11 closing their positions.
164% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 11
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
51% more repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 47
22% more capital invested
Capital invested by funds: $1.7B → $2.08B (+$379M)
11% more funds holding
Funds holding: 152 → 169 (+17)
0.79% less ownership
Funds ownership: 98.76% → 97.97% (-0.79%)
89% less call options, than puts
Call options by funds: $1.97M | Put options by funds: $17.4M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CRCP
Copper Rock Capital Partners
Boston,
Massachusetts
|
+$29.1M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
+$14M |
| 3 |
O
OppenheimerFunds
New York
|
+$13M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$7.17M |
| 5 |
TCM
TimesSquare Capital Management
New York
|
+$5.79M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$36.7M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$20.4M |
| 3 |
William Blair Investment Management
Chicago,
Illinois
|
-$9.81M |
| 4 |
BlackRock
New York
|
-$9.11M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$8.7M |
AMED Hedge Fund Activity: Q2 2017 in Review
169 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q2 2017, worth a combined $2.08B — up 22% from $1.7B a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new AMED positions and 11 closed out — a net gain of 18 holders — while 71 added to existing stakes and 47 trimmed.
The largest buyer was Copper Rock Capital Partners, opening a new position worth an estimated $29.1M. The largest seller was Fidelity Investments, cutting an estimated $36.7M.
- 169 institutional investors held Amedisys (AMED) as of Q2 2017, up from 152 in Q1 2017.
- Funds reported $2.08B of Amedisys stock for Q2 2017, up 22% quarter-over-quarter.
- 29 funds opened new Amedisys positions in Q2 2017 and 11 closed out, a net change of +18 holders.
- The largest Amedisys buyer in Q2 2017 was Copper Rock Capital Partners, an estimated $29.1M added.
- The largest Amedisys seller in Q2 2017 was Fidelity Investments, an estimated $36.7M sold.
Based on aggregated 13F filings for Q2 2017.